16 October 2025

Incanthera plc

("Incanthera" the "Company")

Investor Presentation

Proactive Investor Forum Presentation

Incanthera plc (AQSE:INC), the company specially focussed on innovative technologies in dermatology and oncology, advises that following their presentation at Proactive investor's One2One Biotech Investor Forum in London on 9 October 2025, the recording of the company's presentation is now available on the following link:

https://www.youtube.com/embed/mMnfpaj1ZCE?si=pikzFDks4YpOQ_En

This is also available to view on the Company's website, along with the investor presentation, given on the evening, at https://www.incanthera.com/investors/results-reports-and-presentations/.

RNS Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained in this announcement is of a non-regulatory nature.

For further enquiries:

  Incanthera plc:                                                                                                                                                                 

Notes to Editors

Incanthera is a specialist company focused on innovative technologies in dermatology and oncology. It seeks to identify and develop innovative solutions to current clinical, commercially relevant unmet needs, utilising new technology from leading specialists and academic institutions as well as its in-house development team.

The Company originated from the Institute of Cancer Therapeutics ("ICT") at the University of Bradford.  Incanthera's strategy is to develop each candidate in its portfolio from initial acquisition or discovery to securing its future through commercially valuable partnerships at the earliest opportunity in its development pathway.

For more information on the Company please visit: www.incanthera.com

@incantheraplc